Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0000950123-07-003022
Filing Date
2007-03-01
Accepted
2007-03-01 15:50:01
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-KT y30771e10vkt.htm 10-KT 1405671
2 EX-10.27: EMPLOYMENT AGREEMENT y30771exv10w27.htm EX-10.27 125879
3 EX-21.0: SUBSIDIARIES y30771exv21w0.htm EX-21.0 19845
4 EX-23.1: CONSENT OF DELOITTE & TOUCHE LLP y30771exv23w1.htm EX-23.1 1948
5 EX-23.2: CONSENT OF KPMG HUNGARIA KFT y30771exv23w2.htm EX-23.2 2037
6 EX-31.1: CERTIFICATION y30771exv31w1.htm EX-31.1 8310
7 EX-31.2: CERTIFICATION y30771exv31w2.htm EX-31.2 8704
8 EX-32.O: CERTIFICATIONS y30771exv32w0.htm EX-32.0 4815
  Complete submission text file 0000950123-07-003022.txt   1578713
Mailing Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519
Business Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519 8453621100
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-09860 | Film No.: 07663270
SIC: 2834 Pharmaceutical Preparations